|Christian Schaub, CEO and co-founder
Engineer (masters degree ETH Zurich), successful entrepreneur setting-up hightech business. Business and technology consultant for finance institutes and industrial companies for more than 14 years. De Vigier Prize Winner 2007. Lecturer at ETH Zurich for strategy and marketing.
Dr. Corinne John, CTO and co-founder
|Dr. Sabine Wellnitz, Head of Product Development
Sabine Wellnitz became Head of Product Development in 2009 after joining the company in 2008. Already during her PhD, Sabine gained initial industry experience at Boehringer Mannheim. She later held research positions at Roche and Novartis, where she worked in the field of Alzheimer Disease (Roche) and in the development of a high-throughput screening test for GPCRs on the basis of VLPs (Novartis). Sabine is a molecular virologist with more than 14 years of experience and extensive knowledge in the area of protein expression, viral proteins and VLPs.
Sabine holds a M.Sc. in Biology of the University Karlsruhe and a PhD from the University Freiburg.
|Dr. Christian Mittelholzer, CSO
Christian Mittelholzer became Chief Scientific Officer in 2013 after joining the Company in 2012. He is a molecular biologist by training, with more than 15 years of experience in veterinary and human virology, and more recently in the development of novel vaccines. He was formerly working on self-assembling protein nanoparticles as vaccine candidates at Alpha-O Peptides, and using polyomavirus VLPs at the Institute of Medical Microbiology at the University of Basel.
Christian holds a M.Sc. in Biology of the University of Basel and a PhD from the University of Berne.